Clinical Trial: A multimodal artificial intelligence-based predictive model for immunotherapy efficacy in biliary tract cancer and exploration of its underlying mechanisms. (China)

China, Aug. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A multimodal artificial intelligence-based predictive model for immunotherapy efficacy in biliary tract cancer and exploration of its underlying mechanisms.'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129896

Registration Time: 2026/08/11

Type: Observational study

Primary Sponsor: Yantai Yuhuangding Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=334780

Published by HT Digital Content Services with permission from Health Daily Digest....